IL210813A0 - Methods of administering topical antifungal formulations for the treatment of fungal infections - Google Patents
Methods of administering topical antifungal formulations for the treatment of fungal infectionsInfo
- Publication number
- IL210813A0 IL210813A0 IL210813A IL21081311A IL210813A0 IL 210813 A0 IL210813 A0 IL 210813A0 IL 210813 A IL210813 A IL 210813A IL 21081311 A IL21081311 A IL 21081311A IL 210813 A0 IL210813 A0 IL 210813A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- methods
- fungal infections
- topical antifungal
- antifungal formulations
- Prior art date
Links
- 206010017533 Fungal infection Diseases 0.000 title 1
- 208000031888 Mycoses Diseases 0.000 title 1
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8311508P | 2008-07-23 | 2008-07-23 | |
| US10211108P | 2008-10-02 | 2008-10-02 | |
| US15018709P | 2009-02-05 | 2009-02-05 | |
| US16812209P | 2009-04-09 | 2009-04-09 | |
| PCT/IB2009/006742 WO2010010470A2 (en) | 2008-07-23 | 2009-07-23 | Methods of administering topical antifungal formulations for the treatment of fungal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL210813A0 true IL210813A0 (en) | 2011-04-28 |
Family
ID=41358304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL210813A IL210813A0 (en) | 2008-07-23 | 2011-01-23 | Methods of administering topical antifungal formulations for the treatment of fungal infections |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20100086504A1 (enExample) |
| EP (1) | EP2317993A2 (enExample) |
| JP (1) | JP2011529038A (enExample) |
| KR (1) | KR20110039357A (enExample) |
| CN (1) | CN102159202A (enExample) |
| AU (1) | AU2009275230A1 (enExample) |
| CA (1) | CA2731455A1 (enExample) |
| CL (1) | CL2011000135A1 (enExample) |
| CO (1) | CO6351719A2 (enExample) |
| EC (1) | ECSP11010818A (enExample) |
| IL (1) | IL210813A0 (enExample) |
| MX (1) | MX2011000932A (enExample) |
| NI (1) | NI201100025A (enExample) |
| PE (1) | PE20110642A1 (enExample) |
| WO (1) | WO2010010470A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125529A (zh) | 2007-02-05 | 2015-12-09 | 亲生物有限公司 | 烯丙胺药物化合物的增加的效力 |
| CA2751412A1 (en) * | 2009-02-05 | 2010-08-12 | Targeted Delivery Technologies Limited | Methods of reducing the proliferation and viability of microbial agents |
| FR2954163B1 (fr) * | 2009-12-18 | 2012-03-16 | Galderma Pharma Sa | Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle |
| AU2010336441B2 (en) | 2009-12-23 | 2015-02-05 | Nuvo Research Inc. | Highly permeating terbinafine formulation for treating onychomycosis |
| PL2672962T3 (pl) | 2011-02-11 | 2015-08-31 | Moberg Pharma Ab | Nowa kompozycja przeciwgrzybicza |
| EP2688554A2 (en) * | 2011-03-21 | 2014-01-29 | Gregor Cevc | Optimised preparations of highly adaptable aggregates |
| WO2013057208A1 (en) | 2011-10-18 | 2013-04-25 | Targeted Delivery Technologies Limited | Compositions and methods for reducing the proliferation and viability of microbial agents |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| CA2940494C (en) | 2014-03-14 | 2022-11-08 | Gojo Industries, Inc. | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines |
| AT516544B1 (de) | 2014-12-02 | 2017-05-15 | Universität Innsbruck | Stoffgemisch und Zubereitung |
| CN105193726B (zh) * | 2015-11-08 | 2018-01-26 | 长沙佰顺生物科技有限公司 | 一种治疗灰指甲的药物组合物 |
| US11554108B2 (en) * | 2016-08-29 | 2023-01-17 | Xeropedix, Inc. | Methods and compositions for treating cutaneous fungal infections |
| KR101952715B1 (ko) * | 2017-09-27 | 2019-02-27 | 경희대학교 산학협력단 | 천연 화합물을 포함하는 칸디다증 개선용 항진균 조성물 |
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス，インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
| RU2698454C1 (ru) * | 2018-11-12 | 2019-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ Минздрава России) | Способ лечения онихомикозов стоп |
| KR102072946B1 (ko) | 2019-08-06 | 2020-02-03 | 주식회사 씨엔엘바이오텍 | 조갑진균증 예방 또는 치료용 조성물 |
| JP2022552252A (ja) * | 2019-10-08 | 2022-12-15 | ハルクス，インコーポレイテッド | 爪真菌症治療用組成物及び方法 |
| AT524378A1 (de) | 2020-11-06 | 2022-05-15 | Univ Innsbruck | Zubereitung |
| KR20230116911A (ko) * | 2020-12-08 | 2023-08-04 | 모베르그 파르마 아베 | 알릴아민 항진균 조성물을 사용한 조갑진균증의 치료 요법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1410A (en) * | 1979-08-22 | 1988-04-22 | Sandoz Ag | Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
| US6005001A (en) * | 1991-05-20 | 1999-12-21 | Novartis Ag (Formerly Sandoz Ag) | Pharmaceutical composition |
| GB9111611D0 (en) * | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| EP1059941B1 (en) * | 1998-03-05 | 2004-05-26 | Phares Pharmaceutical Research N.V. | Pharmaceutical compositions and their use |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
| US6846837B2 (en) * | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| US7473432B2 (en) * | 2002-10-11 | 2009-01-06 | Idea Ag | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| WO2005087195A2 (en) * | 2004-03-18 | 2005-09-22 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| WO2006103638A2 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
| US20070077283A1 (en) * | 2005-09-30 | 2007-04-05 | Nastech Pharmaceutical Company Inc. | Method of enhancing transmucosal delivery of therapeutic compounds |
| JP5467722B2 (ja) * | 2007-01-16 | 2014-04-09 | ロート製薬株式会社 | 皮膚外用乳化製剤 |
| CN105125529A (zh) * | 2007-02-05 | 2015-12-09 | 亲生物有限公司 | 烯丙胺药物化合物的增加的效力 |
-
2009
- 2009-07-23 JP JP2011519254A patent/JP2011529038A/ja active Pending
- 2009-07-23 KR KR1020117004207A patent/KR20110039357A/ko not_active Withdrawn
- 2009-07-23 CA CA2731455A patent/CA2731455A1/en not_active Abandoned
- 2009-07-23 EP EP09786211A patent/EP2317993A2/en not_active Withdrawn
- 2009-07-23 PE PE2011000073A patent/PE20110642A1/es not_active Application Discontinuation
- 2009-07-23 CN CN2009801337541A patent/CN102159202A/zh active Pending
- 2009-07-23 US US12/508,537 patent/US20100086504A1/en not_active Abandoned
- 2009-07-23 AU AU2009275230A patent/AU2009275230A1/en not_active Abandoned
- 2009-07-23 WO PCT/IB2009/006742 patent/WO2010010470A2/en not_active Ceased
- 2009-07-23 MX MX2011000932A patent/MX2011000932A/es not_active Application Discontinuation
-
2010
- 2010-01-19 US US12/689,470 patent/US7820720B2/en not_active Expired - Fee Related
-
2011
- 2011-01-21 NI NI201100025A patent/NI201100025A/es unknown
- 2011-01-21 CL CL2011000135A patent/CL2011000135A1/es unknown
- 2011-01-23 IL IL210813A patent/IL210813A0/en unknown
- 2011-02-10 EC EC2011010818A patent/ECSP11010818A/es unknown
- 2011-02-15 CO CO11017742A patent/CO6351719A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6351719A2 (es) | 2011-12-20 |
| JP2011529038A (ja) | 2011-12-01 |
| CL2011000135A1 (es) | 2011-09-23 |
| CA2731455A1 (en) | 2010-01-28 |
| WO2010010470A2 (en) | 2010-01-28 |
| US20100104633A1 (en) | 2010-04-29 |
| WO2010010470A3 (en) | 2010-03-18 |
| AU2009275230A1 (en) | 2010-01-28 |
| US7820720B2 (en) | 2010-10-26 |
| ECSP11010818A (es) | 2011-05-31 |
| KR20110039357A (ko) | 2011-04-15 |
| CN102159202A (zh) | 2011-08-17 |
| PE20110642A1 (es) | 2011-08-31 |
| US20100086504A1 (en) | 2010-04-08 |
| NI201100025A (es) | 2011-11-02 |
| EP2317993A2 (en) | 2011-05-11 |
| MX2011000932A (es) | 2011-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2244709A4 (en) | TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS | |
| TWI367110B (en) | Topical pharmaceutical formulation | |
| IL233247A0 (en) | A topical oil preparation for the treatment of fungal infections | |
| ZA201100653B (en) | Topical composition for the treatment of ctinic keratosis | |
| EP2960233B8 (en) | New therapeutic agents | |
| IL216323A0 (en) | Compositions suitable for the topical treatment of fungal infections of the skin and nails | |
| EP2337617A4 (en) | SQUARE PLASMA FORMULATIONS FOR HEART TREATMENTS | |
| HUE036071T2 (hu) | Macitentánt tartalmazó terápiás készítmények | |
| IL212472A0 (en) | Preservative system for emulsion-based therapeutic topical formulations | |
| WO2010010470A3 (en) | Methods of administering topical antifungal formulations for the treatment of fungal infections | |
| PL2344130T3 (pl) | Kompozycje farmaceutyczne do miejscowego stosowania | |
| WO2010032011A3 (en) | Anti-fungal therapy | |
| WO2012018597A9 (en) | Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments | |
| GB201202095D0 (en) | Topical medicament for the treatment of psoriasis | |
| EP2124938A4 (en) | TOPICAL FORMULATION | |
| IL210975A (en) | Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections | |
| EP2310022A4 (en) | TOPIC MEDICINE | |
| WO2011088020A9 (en) | Modified saponins for the treatment of fungal infections | |
| PL2538938T3 (pl) | Kompozycja do leczenia grzybicy paznokci | |
| PL385972A1 (pl) | Kompozycja farmaceutyczna do leczenia chorób przyzębia | |
| EP2381945A4 (en) | TOPICAL FORMULAS OF FLAP INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES | |
| EP2565184B8 (en) | Therapeutic agent and preventative agent for alzheimer's disease | |
| HK1150558A (en) | Methods of administering topical antifungal formulations for the treatment of fungal infections | |
| PL2431030T3 (pl) | Leczenie infekcji grzybiczych | |
| PL2120953T3 (pl) | Preparaty do miejscowego leczenia chorób skóry |